These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20652713)

  • 1. Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device.
    Pehrsson A; Blencowe T; Vimpari K; Impinen A; Gunnar T; Lillsunde P
    Int J Legal Med; 2011 Sep; 125(5):675-83. PubMed ID: 20652713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
    Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
    Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
    Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
    Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of on-site oral fluid drug screening devices DrugWipe 5+ and Rapid STAT using oral fluid for confirmation analysis.
    Pehrsson A; Blencowe T; Vimpari K; Langel K; Engblom C; Lillsunde P
    J Anal Toxicol; 2011 May; 35(4):211-8. PubMed ID: 21513614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine whole blood concentrations in cases with positive oral fluid on-site screening test results using the DrugWipe(®) single for benzodiazepines.
    Blencowe T; Vimpari K; Lillsunde P
    J Anal Toxicol; 2011 Jul; 35(6):349-56. PubMed ID: 21740691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.
    Röhrich J; Zörntlein S; Becker J; Urban R
    J Anal Toxicol; 2010 Apr; 34(3):155-61. PubMed ID: 20406540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users.
    Samyn N; van Haeren C
    Int J Legal Med; 2000; 113(3):150-4. PubMed ID: 10876986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
    Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
    Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
    Musshoff F; Hokamp EG; Bott U; Madea B
    Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.
    Samyn N; De Boeck G; Verstraete AG
    J Forensic Sci; 2002 Nov; 47(6):1380-7. PubMed ID: 12455668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications.
    Huestis MA
    Clin Chem; 2009 Dec; 55(12):2079-81. PubMed ID: 19833833
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis.
    Strano-Rossi S; Castrignanò E; Anzillotti L; Serpelloni G; Mollica R; Tagliaro F; Pascali JP; di Stefano D; Sgalla R; Chiarotti M
    Forensic Sci Int; 2012 Sep; 221(1-3):70-6. PubMed ID: 22554872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
    Gjerde H; Langel K; Favretto D; Verstraete AG
    Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roadside drug testing: comparison of two legal approaches in Belgium.
    Van der Linden T; Wille SM; Ramírez-Fernandez M; Verstraete AG; Samyn N
    Forensic Sci Int; 2015 Apr; 249():148-55. PubMed ID: 25700110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
    Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
    Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.
    Blencowe T; Pehrsson A; Lillsunde P; Vimpari K; Houwing S; Smink B; Mathijssen R; Van der Linden T; Legrand SA; Pil K; Verstraete A
    Forensic Sci Int; 2011 May; 208(1-3):173-9. PubMed ID: 21183299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
    Matzopoulos R; Lasarow A; Bowman B
    Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs in oral fluid in randomly selected drivers.
    Drummer OH; Gerostamoulos D; Chu M; Swann P; Boorman M; Cairns I
    Forensic Sci Int; 2007 Aug; 170(2-3):105-10. PubMed ID: 17658711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
    Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
    Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.